Sun Pharma Advanced Research Company (SPARC) Q2 net loss at Rs 24 crore
Sun Pharma Advanced Research Company (SPARC) today posted a net loss of Rs 24.12 crore for the second quarter ended September 30.
By PTI | Updated:
NEW DELHI: Sun Pharma Advanced Research Company (SPARC) today posted a net loss of Rs 24.12 crore for the second quarter ended September 30.
The company had posted a net loss of Rs 21.48 crore during the same period of previous fiscal.
Total income of the company stood at Rs 4.85 crore for the second quarter, as compared to Rs 10.17 crore during the same period of 2011-12 fiscal, SPARC said in a statement.
SPARC was demerged from Sun Pharma as a pharma research and drug discovery company in 2007.
The company had posted a net loss of Rs 21.48 crore during the same period of previous fiscal.
Total income of the company stood at Rs 4.85 crore for the second quarter, as compared to Rs 10.17 crore during the same period of 2011-12 fiscal, SPARC said in a statement.
SPARC was demerged from Sun Pharma as a pharma research and drug discovery company in 2007.
Too busy to trade in stocks? Invest in Mutual Funds with ET Money!
Bookmark or read stories offline -
Download ET Markets APP
Download ET Markets APP
Related Articles
Consumer sector beats expectations but faces commodity crunch from Q2, warns BofA Securities2026-06-04T03:30:00Z- Uber Q1 revenue rises 14%, slightly misses estimates; forecasts strong Q2 bookings2026-05-06T11:15:01Z
- US Stock Market: US treasury lifts Q2 borrowing estimate to $189 billion on weaker cash flows2026-05-05T03:57:13Z
ADVERTISEMENT
